Standout Papers

Transarterial Chemoembolization Combined With Lenvatinib Plus PD-1 Inhibitor for Advanced Hepatocellular Carcinoma: A Ret... 2022 2026 2023 2024104
  1. Transarterial Chemoembolization Combined With Lenvatinib Plus PD-1 Inhibitor for Advanced Hepatocellular Carcinoma: A Retrospective Cohort Study (2022)
    Mingyue Cai, Wensou Huang et al. Frontiers in Immunology

Immediate Impact

47 standout
Sub-graph 1 of 20

Citing Papers

Nanotechnology for enhanced nose-to-brain drug delivery in treating neurological diseases
2024 Standout
The interaction of innate immune and adaptive immune system
2024 Standout
2 intermediate papers

Works of Licong Liang being referenced

Development of mesothelin-specific CAR NK-92 cells for the treatment of gastric cancer
2021
Nanodrug with ROS and pH Dual‐Sensitivity Ameliorates Liver Fibrosis via Multicellular Regulation
2020

Author Peers

Author Last Decade Papers Cites
Licong Liang 183 82 77 106 92 21 383
Thomas Yau 243 84 51 171 83 14 356
Wen‐Ping Lin 172 46 60 178 54 28 348
Zhengji Song 117 55 186 107 77 26 440
Zebin Chen 244 28 95 110 72 25 452
Sui Peng 201 41 113 88 70 23 380
Tongguo Si 124 49 69 145 38 27 389
Luca Ielasi 223 79 64 98 71 23 353
Xiaoju Shi 87 31 120 121 84 35 394
Giulia Rovesti 85 38 118 153 66 27 372
Yunxing Shi 127 56 165 58 50 16 345

All Works

Loading papers...

Rankless by CCL
2026